Glucosteril

Glucosteril is a sterile solution for injection that contains glucose monohydrate as its sole active ingredient. Manufactured for the European market, the product is supplied as an intravenous carbohydrate solution without a specified concentration in the label. It is classified as an excipient/solvent and is used in clinical settings to provide an immediate source of glucose via the bloodstream. The formulation is intended for parenteral nutrition and related therapeutic purposes.

Glucosteril is employed in medical practice for several intravenous indications where rapid glucose supplementation or fluid balance is required.

- Treatment of documented hypoglycemia when oral glucose is not feasible. - Component of total parenteral nutrition regimens to meet carbohydrate energy needs. - Supportive fluid and electrolyte replacement in patients unable to tolerate oral intake. - Provision of an energy source during peri‑operative fasting or critical illness. - Adjunct in metabolic testing protocols that require controlled glucose infusion.

When administered intravenously, Glucosteril may be associated with a range of observed effects, most of which are mild and transient, while rare serious reactions can occur.

Common: - Transient rise in blood glucose concentration, typically normalizing within hours. - Mild hyperosmolarity that may cause temporary sensation of thirst. - Local irritation, erythema, or mild pain at the intravenous insertion site. - Nausea, mild abdominal discomfort, or a brief feeling of fullness.

Serious: - Severe hyperglycemia that can require insulin therapy or other medical management. - Immediate hypersensitivity reactions, including rash, pruritus, urticaria, or rare anaphylactic shock. - Electrolyte disturbances, most commonly hypernatremia or shifts in potassium balance. - Fluid overload leading to pulmonary edema, especially in patients with compromised cardiac or renal function.

Clinicians should observe several precautionary measures when selecting Glucosteril for intravenous use to minimize risks and ensure appropriate patient monitoring.

- Verify patient’s baseline blood glucose and adjust infusion rate accordingly. - Assess fluid status and cardiac function to avoid volume overload. - Use caution in patients with renal impairment or electrolyte disturbances. - Monitor for signs of hyperglycemia, especially in diabetic individuals. - Avoid administration in individuals with known hypersensitivity to glucose solutions. - Ensure proper aseptic technique to prevent catheter‑related infections. - Document infusion parameters and patient response in the medical record.

Glucosteril may interact with other intravenous agents or systemic medications; awareness of potential interactions helps maintain therapeutic safety.

Avoid: - Co‑administration with high‑dose insulin infusions without glucose monitoring. - Simultaneous infusion of hypertonic saline solutions that could exacerbate hyperosmolarity. - Mixing with potassium chloride solutions without adjusting electrolyte concentrations.

Use with caution: - Concurrent use of diuretics, which may alter fluid and electrolyte balance. - Administration alongside catecholamines, as they can affect glucose metabolism. - Overlapping infusion with other carbohydrate-containing parenteral nutrition components. - Use in patients receiving glucocorticoids, which may increase risk of hyperglycemia. - Infusion together with blood products that contain dextrose, monitoring for cumulative glucose load.